Signs Asset Transfer Agreement to buy Vanquest Pharma's Tarapur manufacturing facility
Anuh Pharma Ltd has signed an Asset Transfer Agreement (ATA) to purchase the manufacturing facility of Vanquest Pharma Private Limited at Tarapur, Boisar, District Palghar, Maharashtra.
By ScoutQuest · · 2 min read
- Agreed Value of Assets Purchase
- Rs. 72.90 Crore (excluding applicable taxes, fees, etc.)
- Expected Production Increase
- 525 MTPA
- Consideration
- Cash consideration; no shares issued; no nominee on the Board
What has been signed
Anuh Pharma Ltd has signed an Asset Transfer Agreement (ATA) to purchase the manufacturing facility of Vanquest Pharma Private Limited (VPPL), located at F-10, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra. VPPL is described in the update as a private company incorporated in India on 12/06/2019.
Both the BSE and NSE have been informed, with BSE symbol ANUPHR and NSE symbol ANUPHR.
What is being bought
- Assets relating to manufacturing of APIs and Intermediates, i.e. Land, Building, Plant & Machinery, etc.
- The update says the transaction is expected to strengthen the company's production capacity and market presence in manufacturing quality APIs and intermediates.
- Expected to increase production of the Company by 525 MTPA.
- Agreed value of assets purchase is Rs. 72.90 Crore (Rupees Seventy-Two Crore Ninety Lakhs only), excluding applicable taxes, fees, etc.
An Asset Transfer Agreement is a contract to buy assets such as a plant, land and machinery, rather than buying the shares of the company that owns them. Here the update states the company is purchasing assets, and that it does not hold any shareholding in Vanquest Pharma Private Limited.
How it is being paid for
- The transaction involves payment of cash consideration and does not involve the issuance of any shares by the Company.
- No nominees are to be appointed on the Board of Directors of the Company pursuant to the ATA.
- The counterparty is not related to the Company's promoter/promoter group or group companies, and the transaction is not a related party transaction.
- No special rights such as right to appoint directors, first right to share subscription, or right to restrict any change in capital structure are stated for this agreement.
How a retail investor can read it
The two numbers to note are the Rs. 72.90 Crore agreed value of the assets purchase and the expected 525 MTPA increase in production. What the update spells out as the purpose is buying manufacturing assets for APIs and intermediates and strengthening production capacity and market presence. The payment route is cash rather than shares, so no new shares are being issued to the seller on account of this agreement.
Also from Anuh Pharma
Company receives possession of Tarapur manufacturing facility under asset transfer
21 Oct 2026
Board approves investment in manufacturing assets; clears proposal to avail loan of up to ₹ 75 crs
13 Oct 2026
Board approves investment in manufacturing assets for capacity expansion, proposal to avail loan of up to ₹ 75 crs
13 Oct 2026
More numbers
- Agreed value of assets purchaseRs. 72.90 Crore
- Expected increase in production525 MTPA
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.